Skip to main content
Premium Trial:

Request an Annual Quote

Sanger Institute to Use Definiens Image-Analysis Software

NEW YORK, Sept. 12 (GenomeWeb News) - Definiens said today that the Wellcome Trust Sanger Institute has licensed its Cellenger image-analysis software.

 

Researchers at the Sanger Institute will use the software two support two projects, the Atlas of Protein Expression and the Embryo Gene Expression program, Definiens said.

 

Both of these projects are developing terabyte-scale databases of expression data using high-throughput immunohistochemistry. The researchers are using Cellenger to improve the throughput, analysis, and annotation of images generated by these programs.

 

Financial terms of the agreement were not disclosed.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.